IRIS
TORTI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.855
AS - Asia 1.890
EU - Europa 1.866
SA - Sud America 133
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 8.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.684
SG - Singapore 1.374
IT - Italia 871
CN - Cina 295
GB - Regno Unito 262
SE - Svezia 248
DE - Germania 189
CA - Canada 146
BR - Brasile 117
IN - India 85
FI - Finlandia 75
NL - Olanda 46
HK - Hong Kong 30
CZ - Repubblica Ceca 27
FR - Francia 21
MX - Messico 20
RO - Romania 19
UA - Ucraina 18
ES - Italia 17
PL - Polonia 17
JP - Giappone 16
TR - Turchia 16
BD - Bangladesh 15
RU - Federazione Russa 14
ZA - Sudafrica 14
VN - Vietnam 13
A2 - ???statistics.table.value.countryCode.A2??? 9
AT - Austria 8
SA - Arabia Saudita 8
IQ - Iraq 7
AU - Australia 6
CL - Cile 6
EG - Egitto 5
EU - Europa 5
GR - Grecia 5
NG - Nigeria 5
IE - Irlanda 4
IL - Israele 4
IR - Iran 4
NO - Norvegia 4
AM - Armenia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
KE - Kenya 3
KR - Corea 3
LT - Lituania 3
LV - Lettonia 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
DK - Danimarca 2
GH - Ghana 2
JO - Giordania 2
KZ - Kazakistan 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
TZ - Tanzania 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BE - Belgio 1
BW - Botswana 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
HN - Honduras 1
HR - Croazia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 8.808
Salva come PNG Salva come JPEG
Città #
Chandler 900
Singapore 555
Santa Clara 415
Milan 339
Princeton 334
Lawrence 332
London 217
Wilmington 216
Chicago 215
Munich 141
Ottawa 124
Ashburn 116
Des Moines 98
Turku 62
Boardman 59
Rome 44
Los Angeles 38
Pune 34
Norwalk 32
Guangzhou 31
Shanghai 31
Redwood City 29
Catanzaro 28
Olomouc 27
Hong Kong 26
San Francisco 26
Brooklyn 24
Palermo 24
The Dalles 23
Woodbridge 22
Crotone 20
San Nicola Manfredi 20
Wuhan 20
Houston 19
Fairfield 17
New York 17
Beijing 16
Naples 15
Shenzhen 14
Cosenza 13
São Paulo 13
Warsaw 13
Boston 12
Chennai 12
Hanover 12
Helsinki 12
Rende 12
Rui'an 12
Tokyo 12
Redmond 11
Atlanta 10
Charlotte 10
Settingiano 10
Padova 9
Phoenix 9
Taranto 9
Amsterdam 8
Ann Arbor 8
Columbus 8
Johannesburg 8
Bari 7
Quanzhou 7
Seattle 7
Stockholm 7
Assago 6
Falls Church 6
Fayetteville 6
Jiaxing 6
Maryland Heights 6
Mexico City 6
New Delhi 6
Reggio Calabria 6
Ankara 5
Catania 5
Dallas 5
Hanoi 5
Rio de Janeiro 5
Vijayawada 5
Florence 4
Genoa 4
Ho Chi Minh City 4
Manchester 4
Miami 4
Monheim 4
Nanjing 4
Pisa 4
West Jordan 4
Barcelona 3
Belo Horizonte 3
Cambridge 3
Cape Town 3
Casavatore 3
Cascina 3
Clarksburg 3
Dearborn 3
Dhaka 3
Jeddah 3
Las Vegas 3
Montreal 3
Napoli 3
Totale 5.124
Salva come PNG Salva come JPEG
Nome #
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 101
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 79
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 55
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 51
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 49
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 48
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 48
Ochrobactrum anthropi 47
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 46
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 45
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 44
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 43
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 43
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 43
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 43
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 43
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 41
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The resistance and dosage adapted regimens (RADAR) study 41
Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe 41
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 41
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 40
Therapy with RAS inhibitors during the COVID-19 pandemic 40
Virologic and resistance markers in HIV infection: rationale, state of ART and perspective in clinical practice 39
A king in the CASTLE? Optimum initial HIV protease inhibitor. 39
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 39
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 39
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 38
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 38
Adaptive optics optical coherence tomography at 120,000 depth scans/s for non-invasive cellular phenotyping of the living human retina 38
Challenging clinical cases in HCV infection 38
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study 38
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 37
Allozyme divergence and phylogenetic relationships among species of tephritid flies 37
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 37
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 37
A case report of nasopharyngeal carcinoma in a Caucasian Italian man 37
Evolving phenotypes of non-hospitalized patients that indicate long COVID 37
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment 36
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals 36
Response to combination antiretroviral therapy: variation by age - The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group 36
A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 36
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. 36
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 36
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 36
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 35
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 35
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients 35
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? The Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 35
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 35
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 34
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009 33
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitata 33
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 33
Current concerns in HIV antiretroviral therapy 33
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 33
Unboosted Atazanavir for Treatment of HIV Infection Rationale and Recommendations for Use 33
R211K and L214F ho not invariably confer high level phenotypic resistance to thymidine analogs in zidovndine-naive patients with M184V 33
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 33
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 33
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmacoeconomic implications in a population-based setting 33
Increasing clinical virulence in two decades of the Italian HIV epidemic 33
Valutazione economica dei trattamenti anti-HIV: lo studio di coorte I.C.O.N.A. 33
Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the "Magna Graecia", University of Catanzaro 33
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 33
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 32
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 32
A new basal subfamily of mariner elements in Ceratitis rosa and other tephritid flies 32
"Solving the puzzle" of current HAART: What key strategic trials are needed? 32
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia 32
Characterisation of viro-immunlogical responses in a closely followed cohort oh heavily pretreated patients: evidence from the GenPheRex Study 32
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort 32
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 32
RegaDB: community-driven data management and analysis for infectious diseases 32
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 32
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 31
Early virological failure after tenofovir plus didanosine plus efavirenz combination in HIV-positive patients upon starting antiretroviral therapy 31
Genetic differentiation, gene flow and the origin of infestations of the medfly, Ceratitis capitata 31
Risk factors for myocardial infarction in HIV positive patients 31
HIV-1 pharmacoresistance: clinical and therapeutic implications 31
Genetic aspects of the worldwide colonization process of Ceratitis capitata 31
Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 31
Genotyping for guiding drug choice in human immunodeficiency virus-infected children failing multiple antiretroviral treatment regimens 31
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study 31
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis. 31
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure. 31
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 31
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 31
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 30
Intron size polymorphism of the Adh(1) gene parallels the worldwide colonization history of the Mediterranean fruit fly, Ceratitis capitata 30
Characterization and evolution of mariner elements from closely related species of fruit flies (Diptera : Tephritidae) 30
Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound. 30
MASTER Study Group. Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function 30
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients 30
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 30
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 30
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 30
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 30
Outcome of hbv screening and vaccination in a migrant population in southern italy 29
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 29
Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment. 29
Totale 3.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 19 4 91 19 17 31 16 32 34 16 3 9
2021/2022880 9 3 12 236 30 17 41 216 58 104 146 8
2022/20232.570 684 110 20 276 286 244 14 160 402 169 167 38
2023/20241.134 237 147 80 77 69 290 36 24 26 25 60 63
2024/20253.722 543 273 136 136 236 460 67 142 458 232 334 705
2025/2026142 142 0 0 0 0 0 0 0 0 0 0 0
Totale 9.057